Food Insecurity Reduction & Strategy Team
Launched by STANFORD UNIVERSITY · Mar 22, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Food Insecurity Reduction & Strategy Team, is focused on helping people with diabetes who are struggling to get enough healthy food. The study aims to understand the reasons why some patients with diabetes have trouble accessing nutritious food while they are in the hospital. It will also test a special nutrition program to see if it can improve health outcomes for these patients. Participants in the program will receive additional support, including nutritious meals delivered twice a day for up to 90 days after leaving the hospital, as well as education to help them make better food choices.
To be eligible for this trial, participants must be adults aged 65 to 74 who have either Type 1 or Type 2 diabetes, are currently hospitalized at Stanford Healthcare, and have been identified as having food insecurity. They must also live in California and be enrolled in a healthcare plan that covers meals from Mom's Meals. This study is actively recruiting participants and aims to not only improve individual health but also create a sustainable plan to help more people in the community access healthy food in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Type 1 or Type 2 Diabetes Mellitus
- • Admitted to Stanford Healthcare inpatient unit
- • Residence in California at time of enrollment
- • Positive Screening for Food Insecurity
- • On a Healthcare Plan covered by Mom's Meals.
- Exclusion Criteria:
- • Plans to be discharged to a skilled nursing facility.
- • Patients who prefer a language for which a short-form consent is not available.
- • No Home Address
- • Pregnant Participants.
- • No access to refrigerator.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Neera Ahuja, MD
Principal Investigator
Stanford University
Christine Santiago, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported